1. Paradoxical thrombosis in idiopathic thrombocytopenic purpura

   • Osamu Imataki
   • Shumpei Uchida
   • Norimitsu Kadowaki

   Images in Hematology 22 October 2016 Pages: 111 - 112

   

2. Chromosomal translocation t(1;22)(q21;q11) in a patient with angioimmunoblastic T-cell lymphoma

   • Masaaki Adachi
   • Katsuya Nakanishi

   Images in Hematology 22 October 2016 Pages: 113 - 115

   

3. Factors that influence a mobilized HSC product

   • Susan K. Nilsson

   Progress in Hematology 24 December 2016 Pages: 116 - 117

4. Extracellular molecules in hematopoietic stem cell mobilisation

   • Linda Bendall

   Progress in Hematology 08 November 2016 Pages: 118 - 128

   

5. Cellular players of hematopoietic stem cell mobilization in the bone marrow niche

   • Joshua Tay
   • Jean-Pierre Levesque
   • Ingrid G. Winkler

   Progress in Hematology 10 December 2016 Pages: 129 - 140

   

6. New agents in HSC mobilization

   • Mélanie J. Domingues
   • Susan K. Nilsson
   • Benjamin Cao

   Progress in Hematology 30 November 2016 Pages: 141 - 152

   

7. Harnessing bone marrow resident regulatory T cells to improve allogeneic stem cell transplant outcomes

   • Laetitia Le Texier
   • Katie E. Lineburg
   • Kelli P. A. MacDonald

   Progress in Hematology 10 December 2016 Pages: 153 - 161

   

8. Mitophagy is increased during erythroid differentiation in β-thalassemia

   • Limei Wu
   • Wei Xu
   • Jianpei Fang

   Original Article 28 October 2016 Pages: 162 - 173

   

9. A combined approach using global coagulation assays quickly differentiates coagulation disorders with prolonged aPTT and low levels of FVIII activity

   • Tomoko Matsumoto
   • Keiji Nogami
   • Midori Shima

   Original Article 11 October 2016 Pages: 174 - 183

   

10. A retrospective study of azacitidine treatment in patients with intermediate-2 or high risk myelodysplastic syndromes in a real-world clinical setting in Greece

    • Vasiliki Pappa
    • Achilles Anagnostopoulos
    • Argiris Symeonidis

    Original Article 04 November 2016 Pages: 184 - 195

    

11. Wnt signaling inhibitor FH535 selectively inhibits cell proliferation and potentiates imatinib-induced apoptosis in myeloid leukemia cell lines

    • Kran Suknuntha
    • Thanyatip Thita
    • Suradej Hongeng

    Original Article 20 October 2016 Pages: 196 - 205

    

12. Safety of ASP0113, a cytomegalovirus DNA vaccine, in recipients undergoing allogeneic hematopoietic cell transplantation: an open-label phase 2 trial

    • Takehiko Mori
    • Yoshinobu Kanda
    • Yoshihisa Kodera

    Original Article 28 October 2016 Pages: 206 - 212

    

13. Bacteremia during neutropenic episodes in children undergoing hematopoietic stem cell transplantation with ciprofloxacin and penicillin prophylaxis

    • Worawut Choeyprasert
    • Suradej Hongeng
    • Samart Pakakasama

    Original Article 22 October 2016 Pages: 213 - 220

14. Successful management of perioperative hemostasis in a patient with Glanzmann thrombasthenia who underwent a right total mastectomy

    • Yoshiyuki Ogawa
    • Shinji Kunishima
    • Hiroshi Handa

    Case Report 01 October 2016 Pages: 221 - 225

    

15. Constitutional t(8;22)(q24;q11.2) that mimics the variant Burkitt-type translocation in Philadelphia chromosome-positive chronic myeloid leukemia

    • Shinichiro Kawamoto
    • Katsuya Yamamoto
    • Hironobu Minami

    Case Report 29 September 2016 Pages: 226 - 229